Although 3-FEA hasn't been formally examined on the same stage as classic amphetamines, it can be presently assumed that like other substituted amphetamines with substitutions at comparable positions, it most certainly acts generally like a triple reuptake inhibitor and/or releaser in the monoamine neurotransmitters serotonin, dopamine, and norepin